Ravindra Agarwal

Title: Ravindra Agarwal: Innovator in Pharmaceutical Formulations

Introduction

Ravindra Agarwal is a notable inventor based in Udaipur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 6 patents to his name, Agarwal's work has the potential to enhance patient care and medication efficacy.

Latest Patents

One of his latest inventions is the Duloxetine sprinkles, which relates to a multiparticulate sprinkle dosage form comprising duloxetine or a pharmaceutically acceptable salt thereof. This formulation exhibits higher acid resistance compared to commercially available delayed-release formulations. Additionally, it includes various methods for administering these multiparticulate sprinkle dosage forms. Another significant patent is the multi-particulate pharmaceutical composition of quetiapine, which discloses an extended-release multi-particulate sprinkle composition. This composition consists of a plurality of discrete units, each containing quetiapine or a pharmaceutically acceptable salt thereof, along with one or more pharmaceutically acceptable excipients.

Career Highlights

Ravindra Agarwal has worked with prominent companies in the pharmaceutical industry, including Sun Pharmaceutical Industries Limited. His experience in these organizations has contributed to his expertise in drug formulation and development.

Collaborations

Throughout his career, Agarwal has collaborated with talented professionals, including Tarun Singhal and Ravi Kochhar. These collaborations have likely enriched his work and led to innovative solutions in pharmaceutical formulations.

Conclusion

Ravindra Agarwal's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an innovator. His work continues to influence the development of effective drug delivery systems, ultimately benefiting patients worldwide.